Adam David DeVore, MD

Associate Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Duke University, 200 Trent Drive, 4th Floor, Orange Zone, Room 4225, Durham, NC 27710
Phone (919) 681-8434
Email address adam.devore@duke.edu

Adam D. DeVore, MD, MHS

Dr. DeVore is a cardiologist and Assistant Professor of Medicine in the Department of Medicine, Division of Cardiology, at Duke University School of Medicine. His clinical interests include caring for patients and families with heart failure, including those with left ventricular assist devices and heart transplants. He is involved in and leads multiple large studies of patients with heart failure at both Duke University Medical Center and the Duke Clinical Research Institute. He currently serves as the assistant director of the Duke Heart Transplant program and the medical director for the Heart Failure Research Cluster.

He attended medical school at the University of Chicago Pritzker School of Medicine and completed internal medicine residency at Brigham and Women’s Hospital. He then pursued cardiology training at Duke University and solidified his interests in clinical research and heart failure. He completed a research fellowship at the Duke Clinical Research Institute and a Masters of Health Sciences in Clinical Research before completing an advanced heart failure fellowship at Duke University.

The overarching goals of his research are to advance the current understanding of heart failure through clinical trials as well as develop an evidence base for implementation strategies that addresses the gap between heart failure trial results and clinical practice. For example, he has served on the Steering Committees for large clinical trials, including PIONEER-HF and SPIRRIT-HFpEF. Dr. DeVore also published the first clinical trial conducted within the American Heart Association’s Get With The Guidelines-Heart Failure program, a registry-based cluster randomized trial of quality improvement interventions. He is also the principal investigator for CONNECT-HF, a large-scale, pragmatic, cluster-randomized trial at 161 sites in the US evaluating heart failure quality improvement initiatives. Outside of his work on heart failure, Dr. DeVore is  married with 4 children and spends his time corralling them all and coaching Little League baseball.

 

 

Education and Training

  • Fellowship in Advanced Heart Failure, Medicine, Duke University School of Medicine, 2015 - 2016
  • Fellowship in Clinical Research, DCRI, Duke University School of Medicine, 2013 - 2015
  • Fellowship in Cardiovascular Medicine, Medicine, Duke University School of Medicine, 2011 - 2013
  • Internal Medicine Residency, Brigham and Women's Hospital, 2007 - 2010
  • M.D., The University of Chicago, 2007

Publications

Khan, M. S., A. D. DeVore, G. M. Felker, J. Butler, G. C. Fonarow, and S. J. Greene. “Reply: Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction.” Jacc: Heart Failure 10, no. 5 (May 1, 2022): 366–67. https://doi.org/10.1016/j.jchf.2022.02.013.

Full Text

Truby, Lauren K., Sarah Casalinova, Chetan B. Patel, Richa Agarwal, Christopher L. Holley, Robert J. Mentz, Carmelo Milano, Benjamin Bryner, Jacob N. Schroder, and Adam D. DeVore. “Donation After Circulatory Death in Heart Transplantation: History, Outcomes, Clinical Challenges, and Opportunities to Expand the Donor Pool.” J Card Fail, April 18, 2022. https://doi.org/10.1016/j.cardfail.2022.03.353.

PMID
35447338
Full Text

Vidula, Himabindu, Onur Altintas, Scott McNitt, Adam D. DeVore, Edo Y. Birati, Michael V. Genuardi, Farooq H. Sheikh, et al. “Low Blood Pressure Threshold for Adverse Outcomes During Left Ventricular Assist Device Support.” Am J Cardiol 169 (April 15, 2022): 78–85. https://doi.org/10.1016/j.amjcard.2021.12.045.

PMID
35063265
Full Text

Vaduganathan, Muthiah, Stephen J. Greene, Shuaiqi Zhang, Nicole Solomon, Karen Chiswell, Adam D. Devore, Javed Butler, et al. “Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure.” J Card Fail 28, no. 4 (April 2022): 554–63. https://doi.org/10.1016/j.cardfail.2021.11.010.

PMID
34785402
Full Text

Patel, Kershaw V., Neil Keshvani, Ambarish Pandey, Muthiah Vaduganathan, DaJuanicia N. Holmes, Roland A. Matsouaka, Adam D. DeVore, Larry A. Allen, Clyde W. Yancy, and Gregg C. Fonarow. “Association of readmission penalty amount with subsequent 30-day risk standardized readmission and mortality rates among patients hospitalized with heart failure: An analysis of get with the guidelines - heart failure participating centers.” Am Heart J 246 (April 2022): 1–11. https://doi.org/10.1016/j.ahj.2021.12.014.

PMID
34973189
Full Text

Jawitz, Oliver K., Benjamin S. Bryner, Jacob N. Schroder, and Adam D. DeVore. “Donation after circulatory death heart transplantation in the United States: An early report of donor characteristics.” Jtcvs Tech 12 (April 2022): 104–7. https://doi.org/10.1016/j.xjtc.2021.12.014.

PMID
35403023
Full Text

Schjødt, Inge, Søren P. Johnsen, Anna Strömberg, Adam D. DeVore, Jan B. Valentin, and Brian B. Løgstrup. “Evidence-Based Process Performance Measures and Clinical Outcomes in Patients With Incident Heart Failure With Reduced Ejection Fraction: A Danish Nationwide Cohort Study.” Circulation. Cardiovascular Quality and Outcomes 15, no. 4 (April 2022): e007973. https://doi.org/10.1161/circoutcomes.121.007973.

PMID
35272503
Full Text

DeVore, Adam D., Anne S. Hellkamp, Laine Thomas, Nancy M. Albert, Javed Butler, J Herbert Patterson, John A. Spertus, et al. “The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP-HF.” Eur J Heart Fail, March 15, 2022. https://doi.org/10.1002/ejhf.2486.

PMID
35293088
Full Text

Keshvani, Neil, Anurag Mehta, Heather M. Alger, Christine Rutan, Joseph Williams, Shuiaqi Zhang, Rebecca Young, et al. “Heart failure quality of care and in-hospital outcomes during the COVID-19 pandemic: findings from the Get With The Guidelines-Heart Failure registry.” Eur J Heart Fail, March 14, 2022. https://doi.org/10.1002/ejhf.2484.

PMID
35289038
Full Text

Nanni, Alexis N., Matthew Harris, Mara Watson, Zidanyue Yang, Hui-Jie Lee, Adam D. DeVore, and James B. Henderson. “Association of tacrolimus time-to-therapeutic range on renal dysfunction and acute cellular rejection after orthotopic heart transplantation in a high use basiliximab population.” Clin Transplant 36, no. 3 (March 2022): e14542. https://doi.org/10.1111/ctr.14542.

PMID
34797576
Full Text

Pages